IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Core Insights - IDEXX Laboratories, Inc. released its 2024 Corporate Responsibility Report, emphasizing its commitment to enhancing the health and well-being of pets, people, and livestock, aligning with its business strategy [1][3] The Care We Advance - IDEXX advanced its innovation strategy in 2024, launching the IDEXX inVue Dx™ Cellular Analyzer and eight additional new products and services [4] - The company revolutionized cancer care with the launch of IDEXX Cancer Dx™ testing in North America, focusing on early detection of canine lymphoma and planning to expand testing for other canine cancers over the next three years [4] The People We Support - IDEXX enabled access to care for over 79,000 animals in 2024, contributing to a total of over 704,000 animals since 2022 through global social initiatives [4] - The company provided approximately $5.5 million in continuing education credits to veterinary professionals in 2024 [4] - IDEXX logged over 86,000 hours of learning and development, including 23,200 hours dedicated to STEM and AI learning [4] - The company achieved over 25,000 self-reported employee volunteer hours, surpassing its 2025 goal of 15,000 annual volunteer hours [4] - IDEXX reported an 80% engagement rate in its annual employee engagement survey [4] The Planet We Share - IDEXX signed three virtual power purchase agreements to add new clean electricity to the North American and European energy grids [4] - The company increased its commercial fleet's electric and hybrid vehicle composition to over 35% [4] - IDEXX advanced global product circularity by servicing over 34,000 instruments and completing over 90,000 point-of-service upgrades on select IDEXX instruments [4]